Allison Kaye Lombridas Pagarigan, Danai Samutpradit, Weerapat Owattanapanich, Sanya Sukpanichnant
The Fc receptor-like 4 (FcRL4)/immunoglobulin superfamily receptor translocation-associated 1 (IRTA1) immunohistochemical marker has emerged in recent literature as a highly specific-albeit moderately sensitive-marker for marginal zone lymphoma with near consistent negativity reported in mantle cell lymphoma (MCL) cohorts. We report a MCL patient with classic clinical, morphologic, immunophenotypic and genetic findings, but having aberrant FcRL4/IRTA1 co-expression. The aberrant expression and its possible favourable prognostic impact in MCL are discussed.